The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
about
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brainSpatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatmentMetabolic control of dendritic cell activation and function: recent advances and clinical implicationsDynamic Metabolism in Immune ResponseDendritic cell metabolismKainic Acid Induces mTORC1-Dependent Expression of Elmo1 in Hippocampal Neurons.Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells.Animal models to improve our understanding and treatment of suicidal behaviorInhibitory effect of a callophycin A derivative on iNOS expression via inhibition of Akt in lipopolysaccharide-stimulated RAW 264.7 cells.mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia.Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblastsMechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial function.TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activationInvolvement of phosphatase and tensin homolog deleted from chromosome 10 in rodent model of neuropathic pain.IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.When less is more: novel mechanisms of iron conservation.The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE.Increased levels of inosine in a mouse model of inflammationEverolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120.Role of autophagy in the pathogenesis of multiple sclerosis.Berberine Decreased Inducible Nitric Oxide Synthase mRNA Stability through Negative Regulation of Human Antigen R in Lipopolysaccharide-Induced Macrophages.Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.Dysregulation of TTP and HuR plays an important role in cancers.The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes.The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.Exercise increases mTOR signaling in brain regions involved in cognition and emotional behavior.Lrg participates in lipopolysaccharide preconditioning-induced brain ischemia injury via TLR4 signaling pathway.Metabolic Plasticity in Dendritic Cell Responses: Implications in Allergic Asthma.Assessment of motor cortex excitability and inhibition during a cognitive task in individuals with concussion.Anti-inflammation Effects of Oxysophoridine on Cerebral Ischemia-Reperfusion Injury in Mice.Heme and hemoglobin suppress amyloid β-mediated inflammatory activation of mouse astrocytes.
P2860
Q26824833-415A3ECA-ABF0-4B33-B3E9-1C889BB69E6EQ27318635-7FA191E3-06E8-4E20-B688-082EB0CD32EEQ28385947-80FB7145-49BF-4A97-9058-F24C079C289AQ28391962-17A9778A-71C2-4C76-881C-7A7D2936FA79Q28397960-2AEDCF1A-CF11-4FC2-9028-FD791D39466AQ33559297-B2EFB8D3-7D2A-44FD-A075-C7BF95C737A5Q33580909-C86B4806-C684-4888-953D-0697023BA302Q33635653-2F2EDA2A-5E5B-4E13-ADB2-C926500658EEQ33707365-62A7F9F6-E16C-4E00-852F-B1509628A1A3Q34025664-A039DE0E-0B2E-49AC-B5C1-BF34FE676E5AQ34070565-58CF2B29-AF56-4A0C-91B3-CAAB269E4786Q34998949-A7E18120-7FED-4586-97E9-98D5C2FC76D6Q35173133-1E858E9A-08FD-4762-B00F-C6654A0541B1Q35276335-72D886B8-B474-47F4-8697-45FDF2D77F57Q36056823-3964879D-A184-449A-805A-819638A11188Q36483828-5F65C481-F4B0-44D4-92C3-390AA7B2E9A2Q37010253-082776C2-6CB1-4D13-8A77-4D8485479ADBQ37053873-C26EA672-3DCA-4B66-B9AD-3065C42276FFQ37597272-2EAEC2BD-FA3F-4741-A222-933063BF5C6BQ38050335-91BE6F03-4CAB-440A-8CC8-9F38D4132673Q38330960-E7BCCC56-59F8-4D44-8756-4657343628CEQ38562775-212A664F-4789-4F18-8FD0-E13E714C0F1CQ38770238-A448ADF6-F882-49B2-93D6-5543D6B5B30AQ38802590-16A75B53-9BB7-481D-8D2A-BDC38EA02D28Q38958552-93AA32A2-21D4-4400-A065-3378D3F43BDFQ41286620-A88AF967-8CCE-429C-8BD4-36C2FEE58A19Q41850897-2B521EF6-F966-4B97-8AD7-FA9B94799782Q42462727-8AB5B63B-29D4-442B-AD41-A07ADBA82112Q42574092-0AE3B418-3BC6-4EBF-8700-5C71CEF9A276Q47349314-017FB708-F762-4BC5-A3FF-BC627FA3A15AQ47912732-7A87A975-1814-4832-B41A-38FD0476759EQ48128838-B7D35866-0BD6-4CA8-B840-BFD42D0FA933Q48221194-B9947CDC-DD00-403F-9497-FDE97E7F8A41Q52152036-C65F9925-1352-4440-885C-CAB20C45530BQ54976953-7AB8F118-A15F-4F6A-99E1-C549DF931C69
P2860
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@ast
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@en
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@nl
type
label
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@ast
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@en
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@nl
prefLabel
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@ast
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@en
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@nl
P2860
P50
P356
P1476
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.
@en
P2093
Douglas L Feinstein
P2860
P2888
P356
10.1186/1742-2094-8-1
P577
2011-01-05T00:00:00Z
P5875
P6179
1004212766